Repository logo
 

Histone deacetylase 4 promotes type I interferon signaling, restricts DNA viruses, and is degraded via vaccinia virus protein C6.

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Stuart, Jennifer H 
Talbot-Cooper, Callum 
Agrawal-Singh, Shuchi 
Huntly, Brian 

Abstract

Interferons (IFNs) represent an important host defense against viruses. Type I IFNs induce JAK-STAT signaling and expression of IFN-stimulated genes (ISGs), which mediate antiviral activity. Histone deacetylases (HDACs) perform multiple functions in regulating gene expression and some class I HDACs and the class IV HDAC, HDAC11, influence type I IFN signaling. Here, HDAC4, a class II HDAC, is shown to promote type I IFN signaling and coprecipitate with STAT2. Pharmacological inhibition of class II HDAC activity, or knockout of HDAC4 from HEK-293T and HeLa cells, caused a defective response to IFN-α. This defect in HDAC4-/- cells was rescued by reintroduction of HDAC4 or catalytically inactive HDAC4, but not HDAC1 or HDAC5. ChIP analysis showed HDAC4 was recruited to ISG promoters following IFN stimulation and was needed for binding of STAT2 to these promoters. The biological importance of HDAC4 as a virus restriction factor was illustrated by the observations that (i) the replication and spread of vaccinia virus (VACV) and herpes simplex virus type 1 (HSV-1) were enhanced in HDAC4-/- cells and inhibited by overexpression of HDAC4; and (ii) HDAC4 is targeted for proteasomal degradation during VACV infection by VACV protein C6, a multifunctional IFN antagonist that coprecipitates with HDAC4 and is necessary and sufficient for HDAC4 degradation.

Description

Keywords

STAT2 recruitment, histone deactylase 4, immune evasion, type I interferon signaling, vaccinia virus protein C6, Cell Line, Cell Line, Tumor, DNA Viruses, HEK293 Cells, HeLa Cells, Herpesvirus 1, Human, Histone Deacetylases, Humans, Interferon Type I, Repressor Proteins, Signal Transduction, Vaccinia, Vaccinia virus, Viral Proteins, Virus Replication

Journal Title

Proc Natl Acad Sci U S A

Conference Name

Journal ISSN

0027-8424
1091-6490

Volume Title

116

Publisher

Proceedings of the National Academy of Sciences

Rights

All rights reserved
Sponsorship
Wellcome Trust (090315/Z/09/Z)
Wellcome Trust (090315/B/09/A)
Biotechnology and Biological Sciences Research Council (BB/M011194/1)
Medical Research Council (MC_PC_12009)
Medical Research Council (MR/R009708/1)
Biotechnology and Biological Sciences Research Council (1804930)
This work was supported by the Wellcome Trust. GLS is a Wellcome Trust Principal Research Fellow. Yongxu Lu, Andrei I. Smid, Jennifer H. Stuart and Liane Dupont were supported by the Wellcome Trust, Joseph S. Snowden was supported by the Lister Institute and Callum Talbot-Cooper was supported by the BBSRC.